Abstract
To the search of new colon tumor biomarkers in the transition from normal colon (NC) mucosa to adenoma (AD) and adenocarcinoma (AC), we integrated microarray data with the results of a high-throughput proteomic workflow. In proteomic study, we used a modified isoelectric focusing protocol on strips with an immobilized pH gradient to separate peptides labeled with iTRAQ (isobaric tags for relative and absolute quantitation) tags followed by liquid chromatography–tandem mass spectrometry analysis. Gene expression measurements were done using Affymetrix GeneChip HG-U133plus2 microarrays and quantitative reverse transcriptase PCR (q-RT-PCR). We identified 3,886 proteins with at least two peptides. Of them, 1,061 proteins were differentially expressed [FC ≥ 1.5; FDR ≤ 0.01] in two pair-wise comparisons: AD vs. NC and AC vs. AD while 15 and 23 proteins were progressively up-regulated and down-regulated in the NC/AD/AC sequence, respectively. The quantitative proteomic information was subsequently correlated with microarray data. For a collection of genes with the same direction of changes of both mRNA and protein levels, we obtained 785/853/795 genes in AD vs. NC/AC vs. NC/AC vs. AD comparison, respectively. Further evaluation of sequentially altered gene expression by q-RT-PCR on individual samples of 24 NCs, 42 ADs, and 26 ACs confirmed progressive expression of six genes: biglycan, calumenin, collagen type XII, alpha 1 (COL12A1), monoamine oxidase A (MAOA), ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5), and MOCO sulphurase C-terminal domain-containing 2 (MOSC2). Among them, three continuously down-regulated (MAOA, ENTPD5, and MOSC2) and one continuously overexpressed (COL12A1) are reported, to our best knowledge, for the first time in a connection to colon cancer onset.
Similar content being viewed by others
References
Bairoch ABL, Altairac S, Amendolia V, Auchincloss A, Argoud-Puy G, Axelsen K, Baratin D, Blatter MC, Boeckmann B, Bolleman J, Bollondi L, Boutet E, Quintaje SB, Breuza L, Bridge A, deCastro E, Ciapina L, Coral D, Coudert E, Cusin I, Delbard G, Dornevil D, Roggli PD, Duvaud S, Estreicher A, Famiglietti L, Feuermann M, Gehant S, Farriol-Mathis N, Ferro S, Gasteiger E, Gateau A, Gerritsen V, Gos A, Gruaz-Gumowski N, Hinz U, Hulo C, Hulo N, James J, Jimenez S, Jungo F, Junker V, Kappler T, Keller G, Lachaize C, Lane-Guermonprez L, Langendijk-Genevaux P, Lara V, Lemercier P, Le Saux V, Lieberherr D, Lima Tde O, Mangold V, Martin X, Masson P, Michoud K, Moinat M, Morgat A, Mottaz A, Paesano S, Pedruzzi I, Phan I, Pilbout S, Pillet V, Poux S, Pozzato M, Redaschi N, Reynaud S, Rivoire C, Roechert B, Schneider M, Sigrist C, Sonesson K, Staehli S, Stutz A, Sundaram S, Tognolli M, Verbregue L, Veuthey AL, Yip L, Zuletta L, Apweiler R, Alam-Faruque Y, Antunes R, Barrell D, Binns D, Bower L, Browne P, Chan WM, Dimmer E, Eberhardt R, Fedotov A, Foulger R, Garavelli J, Golin R, Horne A, Huntley R, Jacobsen J, Kleen M, Kersey P, Laiho K, Leinonen R, Legge D, Lin Q, Magrane M, Martin MJ, O’Donovan C, Orchard S, O’Rourke J, Patient S, Pruess M, Sitnov A, Stanley E, Corbett M, di Martino G, Donnelly M, Luo J, van Rensburg P, Wu C, Arighi C, Arminski L, Barker W, Chen Y, Hu ZZ, Hua HK, Huang H, Mazumder R, McGarvey P, Natale DA, Nikolskaya A, Petrova N, Suzek BE, Vasudevan S, Vinayaka CR, Yeh LS, Zhang J (2009) The Universal Protein Resource (UniProt) 2009. Nucleic Acids Res 37:D169–174
Barderas R, Babel I, Casal JI (2010) Colorectal cancer proteomics, molecular characterization and biomarker discovery. Proteomics: Clin Appl 4:159–178
Becker JC, Fukui H, Imai Y, Sekikawa A, Kimura T, Yamagishi H, Yoshitake N, Pohle T, Domschke W, Fujimori T (2007) Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer. Scand J Gastroenterol 42:852–858
Blanquez MJ, Regadera J, Marino J, Newman RE, Notario V (2002) Gradual deregulation and loss of PCPH expression in the progression of human laryngeal neoplasia. Mol Carcinog 35:186–195
Blanquez MJ, Arenas MI, Conde I, Tirado OM, Paniagua R, Notario V (2004) Deregulated expression of the PCPH proto-oncogene in human breast cancers. Int J Oncol 25:821–830
Bustin SA, Li SR, Dorudi S (2001) Expression of the Ca2 + -activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer. DNA Cell Biol 20:331–338
Cargile BJ, Sevinsky JR, Essader AS, Stephenson JL Jr, Bundy JL (2005) Immobilized pH gradient isoelectric focusing as a first-dimension separation in shotgun proteomics. J Biomol Tech 16:181–189
Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1:304–313
Choe L, D’Ascenzo M, Relkin NR, Pappin D, Ross P, Williamson B, Guertin S, Pribil P, Lee KH (2007) 8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer’s disease. Proteomics 7:3651–3660
Dowell JA, Frost DC, Zhang J, Li L (2008) Comparison of two-dimensional fractionation techniques for shotgun proteomics. Anal Chem 80:6715–6723
Galamb O, Gyorffy B, Sipos F, Spisak S, Nemeth AM, Miheller P, Tulassay Z, Dinya E, Molnar B (2008) Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers 25:1–16
Galamb O, Sipos F, Spisak S, Galamb B, Krenacs T, Valcz G, Tulassay Z, Molnar B (2009) Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes. Cell Oncol 31:19–29
Honore B, Vorum H (2000) The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 466:11–18
John R, El-Rouby NM, Tomasetto C, Rio MC, Karam SM (2007) Expression of TFF3 during multistep colon carcinogenesis. Histol Histopathol 22:743–751
Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ Jr, Aronow BJ (2007) Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 8:R131
Kwong KY, Bloom GC, Yang I, Boulware D, Coppola D, Haseman J, Chen E, McGrath A, Makusky AJ, Taylor J, Steiner S, Zhou J, Yeatman TJ, Quackenbush J (2005) Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics 86:142–158
Lee S, Bang S, Song K, Lee I (2006) Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16:747–754
Lengqvist J, Uhlen K, Lehtio J (2007) iTRAQ compatibility of peptide immobilized pH gradient isoelectric focusing. Proteomics 7:1746–1752
Liu X, Wang X, Zhang J, Lam EK, Shin VY, Cheng AS, Yu J, Chan FK, Sung JJ, Jin HC (2010) Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene 29:442–450
Mendel RR, Bittner F (2006) Cell biology of molybdenum. Biochim Biophys Acta 1763:621–635
Ostergaard M, Hansen GA, Vorum H, Honore B (2006) Proteomic profiling of fibroblasts reveals a modulating effect of extracellular calumenin on the organization of the actin cytoskeleton. Proteomics 6:3509–3519
Ostrowski J, Wyrwicz LS (2009) Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Expert Rev Mol Diagn 9:623–630
Read R, Hansen G, Kramer J, Finch R, Li L, Vogel P (2009) Ectonucleoside triphosphate diphosphohydrolase type 5 (ENTPD5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest. Vet Pathol 46:491–504
Robson SC, Sevigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2:409–430
Rouzaut A, Recio JA, Notario V (2001) Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines. Radiat Res 155:181–187
Rybaczyk LA, Bashaw MJ, Pathak DR, Huang K (2008) An indicator of cancer: downregulation of monoamine oxidase-A in multiple organs and species. BMC Genomics 9:134
Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J, Ostrowski J (2010) Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS ONE 5:e13091
Stella J, Bavaresco L, Braganhol E, Rockenbach L, Farias PF, Wink MR, Azambuja AA, Barrios CH, Morrone FB, Oliveira Battastini AM (2010) Differential ectonucleotidase expression in human bladder cancer cell lines. Urol Oncol 28:260–267
Uwaje NC, Mueller NS, Maccarrone G, Turck CW (2007) Interrogation of MS/MS search data with an pI Filter algorithm to increase protein identification success. Electrophoresis 28:1867–1874
Wang Y, Ma Y, Lu B, Xu E, Huang Q, Lai M (2007) Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study. Exp Biol Med 232:1152–1159, Maywood, NJ
Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G, Gress TM (2001) Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 121:657–667
Yates JR 3rd (2004) Mass spectral analysis in proteomics. Annu Rev Biophys Biomol Struct 33:297–316
Acknowledgments
This work was supported by grants from the Polish Ministry of Science and Higher Education: PBZ-MNiI-2/1/2005 and R13 010 03 (MS software development). We thank for technical assistance to Magdalena Skrzypczak.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Mikula, M., Rubel, T., Karczmarski, J. et al. Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 11, 215–224 (2011). https://doi.org/10.1007/s10142-010-0200-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10142-010-0200-5